[1]CurrentPatentAssignee:JOHNSON&JOHNSONINC-US2019/308950,2019,A1Locationinpatent:Paragraph0443-0444
1227601-23-1
88912-25-8
33674-97-4
83782-89-2
860444-64-0 | 3-Bromo-4-(dimethylamino)aniline | AA00IDSR | MFCD09966038
865106-46-3 | 2H-1,4-Benzoxazin-3(4h)-one, 6,7-difluoro | AA00IE0X | MFCD01313961
869943-97-5 | 5-Fluoro-2-(4-methylpiperidin-1-yl)aniline | AA00IE7Y | MFCD04971026
873005-49-3 | (2-Iodo-4-(trifluoromethyl)phenyl)methanol | AA00IEE5 | MFCD18398172
875258-18-7 | Ethyl 2-(4-bromo-3-nitrophenyl)acetate | AA00IEL3 | MFCD28133586
88150-42-9 | Amlodipine | AA00IEWU | MFCD00864687
885720-87-6 | 3-Bromo-7-chloro-6-ethyl-5-methylpyrazolo[1,5-a]pyrimidine | AA00IF4W | MFCD22690729
886762-81-8 | 2,3,6-Trifluorophenacyl bromide | AA00IF8Y | MFCD07368691
891785-23-2 | 1-Methoxy-6-bromoisoquinoline | AA00IFIH | MFCD16877645
89641-21-4 | Boronic acid, 1,3,5-benzenetriyltris- | AA00IFPK | MFCD20275289